Viewing Study NCT03158220


Ignite Creation Date: 2025-12-25 @ 4:12 AM
Ignite Modification Date: 2026-03-01 @ 5:37 PM
Study NCT ID: NCT03158220
Status: COMPLETED
Last Update Posted: 2019-11-21
First Post: 2017-05-16
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Immunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult Women (V503-004)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cervical Cancer View
None Vulvar Cancer View
None Vaginal Cancer View
None Genital Warts View
None Human Papillomavirus Infection View
Keywords: